Skip to content
A6425Assembly2023-2024 SessionSame asS7114

Cover EpiPens With Insurance

Official title

“Relates to requiring insurance coverage for epinephrine auto-injectors”

Sponsor Daniel O'DonnellAD-69+31 co-sponsorsAffects Finance
Status
Assembly Floor Calendar
Impact
7/10
Significant
Outcome
Companion signed

Bill progress

Signed via S7114

What's happening

This bill requires health insurance plans in New York to cover at least two epinephrine auto-injector devices annually, capping patient costs at $100.

Why it matters

  1. Reduces Financial Barriers for Allergy Sufferers. By capping out-of-pocket costs for epinephrine auto-injectors at $100 per year, the bill directly addresses the high and often unpredictable prices that have made these life-saving devices unaffordable for some families.

  2. Improves Emergency Preparedness. Ensuring coverage of at least two auto-injectors annually means that individuals (especially children, students, and those with severe allergies) are more likely to have access to a device at home, school, or work—potentially preventing fatal allergic reactions.

  3. Applies Broadly Across Insurance Types. The bill amends multiple sections of insurance law to ensure that the requirement applies to individual, group, and blanket health plans, as well as to health maintenance organizations and indemnity plans, making this protection widespread rather than limited to certain plan types.

  4. Addresses Federal Health Savings Account (HSA) Concerns. The legislation includes specific language to ensure it does not inadvertently make high-deductible HSA-qualified plans ineligible under federal law, preserving access to tax-advantaged accounts while still providing the epinephrine benefit after minimum deductibles are met.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • People with life-threatening allergies

    Those covered by affected policies would gain coverage for at least two medically necessary epinephrine auto-injectors, with annual out-of-pocket costs capped at $100, subject to a federal HSA eligibility exception.

  • Health insurers and health service corporations

    They would have to provide the required coverage for policies issued, renewed or changed on or after January 1, 2026.

  • Enrollees in HSA-qualified high-deductible health plans

    If needed to preserve federal HSA eligibility, the cost-sharing requirement would apply after the federal minimum deductible is met, except for qualifying preventive care.

  • State insurance superintendent

    The bill would give the superintendent a role in determining appropriate deductibles and coinsurance consistent with other policy benefits and the bill’s cost-sharing limits.

Headline styles

Cover EpiPens With Insurance

Plain English, a few words. Used as the page title.

Sponsors

History

  1. Substituted by S7114A
  2. Ordered to third reading rules cal.165
  3. Rules report cal.165
  4. Reported
  5. Reported referred to rules
  6. Print number 6425a
  7. Amend and recommit to insurance
  8. Referred to insurance
  9. Referred to insurance

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S7114Senate

Require Insurance for EpiPens

Signed by Governor · Sponsor Gustavo Rivera

Impact 7 · SignificantSigned into law

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

6425--A

2023-2024 Regular Sessions

IN ASSEMBLY

April 6, 2023

Introduced by M. of A. O'DONNELL, PAULIN, LUNSFORD, LAVINE, WEPRIN, SIMON, BURDICK, DAVILA, STERN, SILLITTI, SIMONE, SHIMSKY, DICKENS, DeSTEFANO, LEMONDES, McDONOUGH, JACOBSON, STECK -- read once and referred to the Committee on Insurance -- recommitted to the Committee on Insurance in accordance with Assembly Rule 3, sec. 2 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT to amend the insurance law, in relation to requiring health insurance plans to provide coverage for epinephrine auto-injector devices

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 39 to read as follows:

(39) (A) Every insurer issuing a policy of accident and health insurance delivered or issued for delivery in this state which provides major medical or similar comprehensive-type coverage shall include coverage for, at a minimum, two medically necessary epinephrine auto-injector devices for the emergency treatment of life-threatening allergic reactions. Such coverage may be subject to annual deductibles and coinsurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy; provided however, the total amount that a covered person is required to pay out-of-pocket for such devices shall be capped at an amount not to exceed one hundred dollars annually regardless of the insured's deductible, copayment, coinsurance or any other cost-sharing requirement. If under federal law, application of this requirement would result in health savings account ineligibility under 26 USC 223, this requirement shall apply for health savings account-qualified high deductible health plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD10597-02-4

deductible under 26 USC 223, except for with respect to items or services that are preventive care pursuant to 26 USC 223(c)(2)(C), in which case the requirements of this paragraph shall apply regardless of whether the minimum deductible under 26 USC 223 has been satisfied.

(B) For the purposes of this paragraph, "epinephrine auto-injector device" shall have the same meaning as provided in paragraph (b) of subdivision one of section three thousand-c of the public health law.

§ 2. Subsection (k) of section 3221 of the insurance law is amended by adding a new paragraph 23 to read as follows:

(23) (A) Every group or blanket policy of accident and health insurance delivered or issued for delivery in this state which provides medical coverage that includes coverage for physician services in a physician's office and every policy which provides major medical or similar comprehensive-type coverage shall provide coverage for, at a minimum, two medically necessary epinephrine auto-injector devices for the emergency treatment of life-threatening allergic reactions. Such coverage may be subject to annual deductibles and coinsurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy; provided however, the total amount that a covered person is required to pay outof-pocket for such devices shall be capped at an amount not to exceed one hundred dollars annually regardless of the insured's deductible, copayment, coinsurance or any other cost-sharing requirement. If under federal law, application of this requirement would result in health savings account ineligibility under 26 USC 223, this requirement shall apply for health savings account-qualified high deductible health plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum deductible under 26 USC 223, except for with respect to items or services that are preventive care pursuant to 26 USC 223(c)(2)(C), in which case the requirements of this paragraph shall apply regardless of whether the minimum deductible under 26 USC 223 has been satisfied.

(B) For the purposes of this paragraph, "epinephrine auto-injector device" shall have the same meaning as provided in paragraph (b) of subdivision one of section three thousand-c of the public health law.

§ 3. Section 4303 of the insurance law is amended by adding a new subsection (vv) to read as follows:

(vv) (1) Every medical expense indemnity corporation, hospital service corporation and health service corporation which provides medical coverage that includes coverage for physician services in a physician's office and every policy which provides major medical or similar comprehensive-type coverage shall provide coverage for, at a minimum, two medically necessary epinephrine auto-injector devices for the emergency treatment of life-threatening allergic reactions. Such coverage may be subject to annual deductibles and coinsurance as may be deemed appropriate by the superintendent and as are consistent with those established for other benefits within a given policy; provided however, the total amount that a covered person is required to pay out-of-pocket for such devices shall be capped at an amount not to exceed one hundred dollars annually regardless of the insured's deductible, copayment, coinsurance or any other cost-sharing requirement. If under federal law, application of this requirement would result in health savings account ineligibility under 26 USC 223, this requirement shall apply for health savings account-qualified high deductible health plans with respect to the deductible of such a plan after the enrollee has satisfied the minimum deductible under 26 USC 223, except for with respect to items or services that are preventive care pursuant to 26 USC 223(c)(2)(C), in which case the requirements of this paragraph shall apply regardless of whether the minimum deductible under 26 USC 223 has been satisfied.

(2) For the purposes of this subsection, "epinephrine auto-injector device" shall have the same meaning as provided in paragraph (b) of subdivision one of section three thousand-c of the public health law.

§ 4. This act shall take effect January 1, 2026 and shall apply to all policies and contracts issued, renewed, modified, altered or amended on or after such date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.